Defective megakaryocytic development in myelodysplastic syndromes

Leukemia and Lymphoma

Volumn 38, Issue 1-2, 2000, Pages 13-19

  Hofmann, Wolf Karsten ^a,b   Kalina, Uwe ^a   Koschmieder, Steffen ^a   Seipelt, Gernot ^a   Hoelzer, Dieter ^a   Ottmann, Oliver Gerhard ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

c mpl receptor; MDS; Megakaryocytes; Myelodysplastic syndrome; Thrombopoietin; TPO

Indexed keywords

GROWTH FACTOR RECEPTOR; THROMBOPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOGENETICS; MEGAKARYOPOIESIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034050412     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009060315     Document Type: Review

References (60)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol, 51(2), 189-199.
2. Pierre RV, Catovsky D, Mufti GJ, Swansbury GJ, Mecucci C, Dewald GW, Ruutu T, van den Berghe H, Rowley JD, Mitelman F (1989) Clinical-cytogenetic correlations in myelodysplasia (preleukemia). Cancer Genet Cytogenet, 40(2), 149-161.
3. Mecucci C, van den Berghe H (1992) Cytogenetics. Hematol Oncol Clin North Am, 6(3), 523-541.
4. Mufti GJ (1992) Chromosomal deletions in the myelodysplastic syndrome. Leuk Res, 16(1), 35-41.
5. Mecucci C (1998) Molecular features of primary MDS with cytogenetic changes. Leuk Res, 22(4), 293-302.
6. Hofmann WK, Ottmann OG, Ganser A, Hoelzer D (1996) Myelodysplastic syndromes: clinical features. Semin Hematol, 33(3), 177-185.
7. Parker JE, Mufti GJ (1998) Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes. Br J Haematol, 101(2), 220-230.
8. Greenberg PL (1998) Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatment. Leuk Res, 22(12), 1123-1136.
9. Seipelt G, Ganser A, Duranceyk H, Maurer A, Ottmann OG, Hoelzer D (1993) Induction of TNF-alpha in patients with myelodysplastic syndromes undergoing treatment with interleukin-3. Br J Haematol, 84(4), 749-751.
10. Maslak P, Nimer SD (1998) The efficacy of IL-3, SCF, IL-6, and IL-11 in treating thrombocytopenia. Semin Hematol, 35(3), 253-260.
11. Nichol JL, Hokom MM, Hornkohl A, Sheridan WP, Ohashi H, Kato T, Li YS, Bartley TD, Choi E, Bogenberger J (1995) Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. J Clin Invest, 95(6), 2973-2978.
12. Kuter DJ, Gminski DM, Rosenberg RD (1992) Transforming growth factor beta inhibits megakaryocyte growth and endomitosis. Blood, 79(3), 619-626.
13. Ganser A, Carlo-Stella C, Greher J, Volkers B, Hoelzer D (1987) Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells. Blood, 70(4), 1173-1179.
14. Bruno E, Hoffman R (1998) Human megakaryocyte progenitor cells. Semin Hematol, 35(3), 183-191.
15. Avraham H (1993) Regulation of megakaryocytopoiesis. Stem Cells, 11(6), 499-510.
16. Pellegrini W, Facchetti F, Marocolo D, Salvi L, Capucci A, Tironi A, Rossi G (1995) Assessment of cell proliferation in normal and pathological bone marrow biopsies: a study using double sequential immunophenotyping on paraffin sections. Histopathology, 27(5), 397-405.
17. Thiele J, Hoffmann I, Bertsch HP, Fischer R (1993) Myelodysplastic syndromes: immunohistochemical and morphometric evaluation of proliferative activity in erythropoiesis and endoreduplicative capacity of megakaryocytes. Virchows Arch A Pathol Anat Histopathol, 423(1), 33-38.
18. Wendling F, Maraskovsky E, Debili N, Florindo C, Teepe M, Titeux M, Methia N, Breton-Gorius J, Cosman D, Vainchenker W (1994) cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature. 369(6481), 571-574.
19. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Heipel MD, Burkhead SK, Kramer JM (1994) Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature, 369(6481), 565-568.
20. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang WJ (1994) Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature, 369(6481), 533-538.
21. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samal B, Nichol JL, Swift S (1994) Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl, Cell, 77(7), 1117-1124.
22. Kuter DJ, Beeler DL, Rosenberg RD (1994) The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci U S A, 91(23), 11104-11108.
23. Vigon I, Mornon JP, Cocault L, Mitjavila MT, Tambourin P, Gisselbrecht S, Souyri M (1992) Molecular cloning and characterisation of MPL, the human homolog of the v-mpl oncogene: identification of a memher of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci U S A, 89(12), 5640-5644.
24. Debili N, Wendling F, Cosman D, Titeux M, Florindo C, Dusanter-Fourt I, Schooley K, Methia N, Charon M, Nador R, Bettaieb A, Vainchenker W (1995) The mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood, 85(2), 391-401.
25. Young JC, Bruno E, Luens KM, Wu S, Backer M, Murray LJ (1996) Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+Thy-1+Lin-primitive progenitor cells. Blood, 88(5), 1619-1631.
26. Matsunaga T, Kato T, Miyazaki H, Ogawa M (1998) Thrombopoietin promotes the survival of murine hematopoietic long-term reconstituting cells: comparison with the effects of FLT3/FLK-2 ligand and interleukin-6. Blood, 92(2), 452-461.
27. Tanimukai S, Kimura T, Sakabe H, Ohmizono Y, Kato T, Miyazaki H, Yamagishi H, Sonoda Y (1997) Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro. Exp Hematol, 25(10), 1025-1033.
28. Souyri M (1998) Mpl: from an acute myeloproliferative virus to the isolation of the long sought thrombopoietin. Semin Hematol, 35(3), 222-231.
29. Rojnuckarin P, Drachman JG, Kaushansky K (1999) Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis. Blood, 94(4), 1273-1282.
30. Moliterno AR, Hankins WD, Spivak JL (1998) Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med, 338(9), 572-580.
31. Yoshida Y, Oguma S, Uchino H, Maekawa T (1988) Refractory myelodysplastic anaemias with hypocellular bone marrow. J Clin Pathol, 41(7), 763-767.
32. Ohshima K, Kikuchi M, Takeshita M (1995) A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders. J Pathol, 177(2), 181-189.
33. Kobayashi Y, Uoshima N, Kimura S, Tanaka K, Wada K, Ozawa M, Maruo N, Kondo M (1995) Relationship between morphological classification of the degree of maturation and the ploidy of micromegakaryocytes in myelodysplastic syndrome patients. Int J Hematol, 61(3), 117-122.
34. Kobayashi Y, Ozawa M, Maruo N, Kondo M (1993) Megakaryocytic ploidy in myelodysplastic syndromes. Leuk Lymphoma, 9(1-2), 55-61.
35. Thiele J, Quitmann H, Wagner S, Fischer R (1991) Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens. J Clin Pathol, 44(4), 300-305.
36. Wong KF, Chan JK (1991) Are "dysplastic" and hypogranular megakaryocytes specific markers for myelodysplastic syndrome? Br J Haematol, 77(4), 509-514.
37. Erber WN, Jacobs A, Oscier DG, O'Hea AM, Mason DY (1987) Circulating micromegakaryocytes in myelodysplasia. J Clin Pathol, 40(11), 1349-1352.
38. Lambertenghi-Deliliers G, Orazi A, Luksch R, Annaloro C, Soligo D (1991) Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity. Br J Haematol, 78(2), 161-166.
39. Rebel VI, Huijgens PC, Wijermans PW, van der Valk P, Langenhuijsen MM (1991) Coexistence of myelofibrosis and focal osteolysis with clusters of megakaryocytes and necrosis in a patient with trilineage myelodysplastic syndrome. Eur J Haematol, 47(2), 155-157.
40. Lintula R, Rasi V, Ikkala E, Borgstrom GH, Vuopio P (1981) Platelet function in preleukaemia. Scand J Haematol, 26(1), 65-71.
41. Maldonado JE, Pierre RV (1975) The platelets in preleukemia and myelomonocytic leukemia. Ultrastructural cytochemistry and cytogenetics. Mayo Clin Proc, 50(10), 573-587.
42. Thiede T, Engquist L, Billstrom R (1988) Application of megakaryocytic morphology in diagnosing 5q-syndrome. Eur J Haematol, 41(5), 434-437.
43. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89(6), 2079-2088.
44. Carter G, Ridge S, Padua RA (1992) Genetic lesions in preleukemia. Crit Rev Oncog, 3(4), 339-364.
45. Willman CL, Sever CE, Pallavicini MC, Harada H, Tanaka N, Slovak ML, Yamamoto H, Harada K, Meeker TC, List AF (1993) Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science, 259(5097), 968-971.
46. Geissler D, Zwierzina H, Pechlaner C, Gaggl S, Schmalzl F, Konwalinka G, Braunsteiner H (1989) Abnormal megakaryopoiesis in patients with myelodysplastic syndromes: analysis of cellular and humoral defects. Br J Haematol, 73(1), 29-35.
47. Juvonen E, Partanen S, Knuutila S, Ruutu T (1989) Colony formation by megakaryocyte progenitors in myelodysplatic syndromes. Eur J Haematol. 42(4), 389-395.
48. Dan K, An E, Futaki M, Inokuchi K, Gomi S, Yamada T, Ogata K, Tanabe Y, Ohki I, Shinohara T (1993) Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes. Acta Haematol, 89(3), 113-118.
49. Adams JA, Liu Yin JA, Brereton ML, Briggs M, Burgess R, Hyde K (1997) The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia. Br J Haematol, 99(1), 139-146.
50. Fontenay-Roupie M, Dupont JM, Picard F, Fichelson S, Botella A, Melle J, Guesnu M, Casadevall N, Dreyfus F, Bouscary D (1998) Analysis of megakaryocyte growth and development factor (thrombopoietin) effects on blast cell and megakaryocyte growth in myelodysplasia. Leuk Res, 22(6), 527-535.
51. Hatfill SJ, Fester ED, Steytler JG (1992) Apoplotic megakaryocyte dysplasia in the myelodysplastic syndromes. Hematol Pathol, 6(2), 87-93.
52. Kroemer G (1998) The mitochondrion as an integrator/coordinator of cell death pathways. Cell Death Differ, 5(6), 547.
53. Gattermann N, Retzlaff S, Wang YL, Hofhaus G, Heinisch J, Aul C, Schneider W (1997) Heteroplasmic point mutations of mitochondrial DNA affecting subunit 1 of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemia. Blood, 90(12), 4961-4972.
54. Hofmann WK, Kalina U, Wagner S, Seipelt G, Ries C, Hoelzer D, Ottmann OG (1999) Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes. Exp Hematol, 27(3), 295-400.
55. Bouscary D, Preudhomme C, Ribrag V, Melle J, Viguie F, Picard F, Guesnu M, Fenaux P, Gisselbrecht S, Dreyfus F (1995) Prognostic value of c-mpl expression in myelodysplastic syndromes. Leukemia, 9(5), 783-788.
56. Quentmeier H, Zaborski M, Graf G, Ludwig WD, Drexler HG (1996) Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells. Leukemia, 10(2), 297-310.
57. Solar GP, Kerr WG, Zeigler FC, Hess D, Donahue C, de Sauvage FJ, Eaton DL (1998) Role of c-mpl in early hematopoiesis. Blood, 92(1), 4-10.
58. Miyakawa Y, Oda A, Druker BJ, Kato T, Miyazaki H, Handa M, Ikeda Y (1995) Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and She in human blood platelets. Blood, 86(1), 23-27.
59. Miyakawa Y, Oda A, Druker BJ, Miyazaki H, Handa M, Ohashi H, Ikeda Y (1996) Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets. Blood, 87(2), 439-446.
60. Drachman JG, Kaushansky K (1997) Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain. Proc Natl Acad Sci U S A, 94(6), 2350-2355.